We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$493M
AUM Growth
+$24M
(+5.1%)
Cap. Flow
+$24.3M
Cap. Flow
% of AUM
4.93%
Top 10 Holdings %
Top 10 Hldgs %
73.64%
Holding
90
New
10
Increased
4
Reduced
3
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNA
Paragon 28, Inc.
FNA
|
+$31.7M |
| 2 |
Insmed
INSM
|
+$5.68M |
| 3 |
Ashland
ASH
|
+$3.75M |
| 4 |
Dragonfly Energy
DFLI
|
+$2.48M |
| 5 |
DuPont de Nemours
DD
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$16.4M |
| 2 |
Thor Industries
THO
|
+$12.4M |
| 3 |
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
|
+$2.29M |
| 4 |
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
|
+$267K |
| 5 |
iSpecimen
ISPC
|
+$88.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Consumer Discretionary | 18.86% |
| 3 | Miscellaneous | 17.38% |
| 4 | Industrials | 13.81% |
| 5 | Materials | 10.85% |
Similar funds
NFW
IRC
SCM
PHC
EPM
BCM
FAM
WDG
Bleichroeder LP's Q2 2023 Portfolio in Review
As of Q2 2023, Bleichroeder LP held 90 positions worth $493M, up 5.1% from $469M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Bleichroeder LP deployed $24.3M of net new capital in Q2 2023, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
On the sell side, the largest reduction was Thor Industries, an estimated $12.4M trimmed.
- Bleichroeder LP's largest Q2 2023 buy was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
- Bleichroeder LP added most to Insmed in Q2 2023, an estimated $5.68M increase.
- Bleichroeder LP's biggest Q2 2023 reduction was Thor Industries, cutting an estimated $12.4M.
- Bleichroeder LP fully exited CTI BioPharma Corp. (DE) Common Stock in Q2 2023, selling an estimated $16.4M.
- Bleichroeder LP's ten largest holdings make up 74% of its $493M portfolio in Q2 2023.
- Bleichroeder LP opened 10 new positions and closed 7 in Q2 2023.
- Bleichroeder LP's portfolio value rose 5.1% quarter-over-quarter to $493M.
Based on Bleichroeder LP's 13F filing for Q2 2023, filed 14 Aug 2023.